The biotech firm says it's in ongoing discussions with “commercial third parties” interested in out-licence deals across all its programmes.
Full interview: ReNeuron in active on-going talks for further potential out-licence deals
Quick facts: ReNeuron Group PLC
Price: 173 GBX
Market Cap: £55.07 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of ReNeuron Group PLC named herein, including the promotion by the Company of ReNeuron Group PLC in any Content on the Site, the Company receives...FOR OUR FULL DISCLAIMER CLICK HERE